Image

Cardiac Morphology and Function in Individuals With Autonomic Dysreflexia

Cardiac Morphology and Function in Individuals With Autonomic Dysreflexia

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This case-control study aims to investigate left ventricular remodeling in individuals with chronic spinal cord injury or disease (SCI/D) (≥10 years) and autonomic dysreflexia (AD) who have no prior cardiovascular history. The primary objective is to compare cardiac changes between 24 individuals with high-level SCI/D (above Th6) who have AD and 24 individuals with low-level SCI/D (below Th10) who do not have AD. A secondary objective examines how factors such as age, sex, injury duration, and physical activity are associated with cardiac remodeling.

All 48 participants will undergo cardiac MRI as well as blood measurement of B-type natriuretic peptid to assess cardiac morphology and function. The findings could shed light on a potentially underestimated cardiovascular risk factor in the SCI/D population.

Eligibility

Inclusion Criteria:

  • adults aged 18 years or older
  • long-term (\>10 years), motor-complete SCI/D (AIS A and B)
  • Group A (24 individuals): high-level (\>Th6) SCI/D and autonomic dysreflexia
  • Group B (24 individuals): low-level (\<Th10) SCI/D without autonomic dysreflexia
  • signed informed consent

Exclusion Criteria:

  • congenital heart defects
  • valvular disease(s)
  • cardiomyopathy
  • medium to severe arrhythmia
  • myocardial infarction
  • comorbidities causing morphologic heart changes including primary hypertension, aortic stenosis
  • comorbidities causing arterial hypertension
  • use of anti-hypertensive treatment
  • smokers
  • individuals after sacral deafferentation surgery
  • pregnancy
  • active implanted medical devices
  • claustrophobia
  • inability to comply with the measurement procedures

Study details
    Autonomic Dysreflexia
    Spinal Cord Injuries and Disorders (SCI/D)
    Cardiac Remodeling

NCT07456722

Swiss Paraplegic Research, Nottwil

20 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.